The Latest Cardiac and Vascular News
– WatchPAT™ Revenues Increase 15% to $5.8 Million – – U.S. WatchPAT Revenues Increase 34% to $4.3 Million – – Total Revenues Increase 11% to $6.1 Million – CAESAREA, Israel, May 21, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic […]
PARIS and BUELACH, Switzerland, May 21, 2019 /PRNewswire/ — Focusing on patients with small vessels, three-year outcomes of the BIO-RESORT randomized controlled trial (RCT) showed a significantly lower target lesion revascularization (TLR) rate and thus better efficacy of the Orsiro® drug-eluting stent1 (DES) in comparison to the Resolute Integrity DES.2 Prof. Clemens von Birgelen, Thoraxcentrum Twente, MST, Enschede, the […]
WALTHAM, Mass., May 21, 2019 /PRNewswire/ — Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced the appointment of Dr. Preston Klassen, M.D., M.H.S. to its Board of Directors. Dr. Klassen is presently Executive Vice President, Head of Research and Development at Arena Pharmaceuticals, Inc. (Nasdaq: ARNA). A nephrologist with more than 20 years […]
ALBANY, Ga., May 21, 2019 /PRNewswire/ — A large-scale study recently published in the American Heart Association’s journal, Circulation, showed that higher levels of linoleic acid in the body are associated with a lower risk of major cardiovascular events. Specifically, linoleic acid, the main omega-6 fat found in peanuts, was associated with a 22-percent […]
METAMORA, Mich., May 21, 2019 /PRNewswire/ — In 1908, a Russian scientist (Alexander Ignatowski) thought that eating too much protein would speed up the aging process in humans. To test this hypothesis, he fed rabbits meat, milk and eggs and found ‘fatty streaks’ accumulated in the arteries. In 1913, Nikolai Anichkov, repeated the […]
LAS VEGAS–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces that new data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients from 35 sites demonstrates 72% survival with 98% native heart recovery at discharge. The patients were treated with the NCSI protocol, which includes placing the Impella heart pump before […]
PARIS, May 21, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced positive late-breaking data from its TRILUMINATE study of the company’s minimally invasive tricuspid valve repair system. Results at 30 days demonstrated that the investigational device is associated with a reduction of tricuspid regurgitation (TR) symptoms – caused by a leaky tricuspid heart valve […]
Integrating best-in-class physiology, imaging and co-registration tools across the interventional lab workflow supports physicians in providing cardiac and peripheral vascular patients with superior care Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the new IntraSight interventional applications platform. The secure, application-based […]
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, […]
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the first quarter of 2019 and filed its quarterly report on Form 10-Q for the three months ended March […]
